These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27543389)

  • 1. Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity.
    Zhou Y; McGillick BE; Teng YG; Haranahalli K; Ojima I; Swaminathan S; Rizzo RC
    Bioorg Med Chem; 2016 Oct; 24(20):4875-4889. PubMed ID: 27543389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure-activity relationship and a pharmacophore model.
    Kumar G; Agarwal R; Swaminathan S
    Bioorg Med Chem; 2016 Sep; 24(18):3978-3985. PubMed ID: 27353886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted 8-hydroxyquinoline fragment based small molecule drug discovery against neglected botulinum neurotoxin type F.
    Chauhan R; Chauhan V; Sonkar P; Vimal M; Dhaked RK
    Bioorg Chem; 2019 Nov; 92():103297. PubMed ID: 31557621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A.
    Roxas-Duncan V; Enyedy I; Montgomery VA; Eccard VS; Carrington MA; Lai H; Gul N; Yang DC; Smith LA
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3478-86. PubMed ID: 19528275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a fluorene class of compounds as inhibitors of botulinum neurotoxin serotype E by virtual screening.
    Kumar G; Agarwal R; Swaminathan S
    Chem Commun (Camb); 2012 Feb; 48(18):2412-4. PubMed ID: 22274537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for lead discovery: application of footprint similarity targeting HIVgp41.
    Holden PM; Allen WJ; Gochin M; Rizzo RC
    Bioorg Med Chem; 2014 Jan; 22(1):651-61. PubMed ID: 24315195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity.
    Burnett JC; Schmidt JJ; Stafford RG; Panchal RG; Nguyen TL; Hermone AR; Vennerstrom JL; McGrath CF; Lane DJ; Sausville EA; Zaharevitz DW; Gussio R; Bavari S
    Biochem Biophys Res Commun; 2003 Oct; 310(1):84-93. PubMed ID: 14511652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo inhibition of Clostridium botulinum neurotoxin types B, C, E, and F by small molecular weight inhibitors.
    Montgomery VA; Ahmed SA; Olson MA; Mizanur RM; Stafford RG; Roxas-Duncan VI; Smith LA
    Toxicon; 2015 May; 98():12-9. PubMed ID: 25707753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatase Inhibitors Function as Novel, Broad Spectrum Botulinum Neurotoxin Antagonists in Mouse and Human Embryonic Stem Cell-Derived Motor Neuron-Based Assays.
    Kiris E; Nuss JE; Stanford SM; Wanner LM; Cazares L; Maestre MF; Du HT; Gomba GY; Burnett JC; Gussio R; Bottini N; Panchal RG; Kane CD; Tessarollo L; Bavari S
    PLoS One; 2015; 10(6):e0129264. PubMed ID: 26061731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design.
    Agarwal R; Binz T; Swaminathan S
    Biochemistry; 2005 Sep; 44(35):11758-65. PubMed ID: 16128577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual medicinal chemistry: in silico pre-docking functional group transformation for discovery of novel inhibitors of botulinum toxin serotype A light chain.
    O'Malley S; Sareth S; Jiao GS; Kim S; Thai A; Cregar-Hernandez L; McKasson L; Margosiak SA; Johnson AT
    Bioorg Med Chem Lett; 2013 May; 23(9):2505-11. PubMed ID: 23545109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule quinolinol inhibitor identified provides protection against BoNT/A in mice.
    Singh P; Singh MK; Chaudhary D; Chauhan V; Bharadwaj P; Pandey A; Upadhyay N; Dhaked RK
    PLoS One; 2012; 7(10):e47110. PubMed ID: 23071727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin.
    Maslanka SE; Lúquez C; Dykes JK; Tepp WH; Pier CL; Pellett S; Raphael BH; Kalb SR; Barr JR; Rao A; Johnson EA
    J Infect Dis; 2016 Feb; 213(3):379-85. PubMed ID: 26068781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking Simulation and Sandwich Assay for Aptamer-Based Botulinum Neurotoxin Type C Detection.
    Oh IH; Park DY; Cha JM; Shin WR; Ahn JY; Kim YH; Kim JH; Kim SC; Cho BK
    Biosensors (Basel); 2020 Aug; 10(8):. PubMed ID: 32806662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Integrated Pharmacophore/Docking/3D-QSAR Approach to Screening a Large Library of Products in Search of Future Botulinum Neurotoxin A Inhibitors.
    Gentile D; Floresta G; Patamia V; Chiaramonte R; Mauro GL; Rescifina A; Vecchio M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments with metalloprotease inhibitor class of drug candidates for botulinum neurotoxins.
    Kumar G; Swaminathan S
    Curr Top Med Chem; 2015; 15(7):685-95. PubMed ID: 25751268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A.
    Teng YH; Berger WT; Nesbitt NM; Kumar K; Balius TE; Rizzo RC; Tonge PJ; Ojima I; Swaminathan S
    Bioorg Med Chem; 2015 Sep; 23(17):5489-95. PubMed ID: 26275678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational sampling of the botulinum neurotoxin serotype A light chain: implications for inhibitor binding.
    Burnett JC; Schmidt JJ; McGrath CF; Nguyen TL; Hermone AR; Panchal RG; Vennerstrom JL; Kodukula K; Zaharevitz DW; Gussio R; Bavari S
    Bioorg Med Chem; 2005 Jan; 13(2):333-41. PubMed ID: 15598556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Botulinum Neurotoxin Serotype A Metalloprotease Inhibitors: Analogs of a Chemotype for Therapeutic Development in the Context of a Three-Zone Pharmacophore.
    Burnett JC; Li B; Pai R; Cardinale SC; Butler MM; Peet NP; Moir D; Bavari S; Bowlin T
    Open Access Bioinformatics; 2010 Apr; 2010(2):11-18. PubMed ID: 21103387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.